Literature DB >> 10567208

Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown.

N G Milton1.   

Abstract

Amyloid-beta (Abeta) specifically bound purified catalase with high affinity and inhibited catalase breakdown of H(2)O(2). The Abeta-induced catalase inhibition involved formation of the inactive catalase Compound II and was reversible. Catalase<-->Abeta interactions provide rapid functional assays for the cytotoxic domain of Abeta and suggest a mechanism for some of the observed actions of Abeta plus catalase in vitro.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10567208      PMCID： PMC1220643     

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  30 in total

1.  Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

Authors:  M A Pappolla; R A Omar; K S Kim; N K Robakis
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

2.  Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation.

Authors:  T Dyrks; E Dyrks; T Hartmann; C Masters; K Beyreuther
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

3.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

4.  A simple method for determination of serum catalase activity and revision of reference range.

Authors:  L Góth
Journal:  Clin Chim Acta       Date:  1991-02-15       Impact factor: 3.786

Review 5.  Biochemistry of altered brain proteins in Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

6.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.

Authors:  B Friguet; A F Chaffotte; L Djavadi-Ohaniance; M E Goldberg
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

7.  Production and utilization of monoclonal antibodies to human/rat corticotrophin-releasing factor-41.

Authors:  N G Milton; E W Hillhouse; S A Nicholson; C H Self; A M McGregor
Journal:  J Mol Endocrinol       Date:  1990-10       Impact factor: 5.098

8.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

Authors:  X Huang; C S Atwood; M A Hartshorn; G Multhaup; L E Goldstein; R C Scarpa; M P Cuajungco; D N Gray; J Lim; R D Moir; R E Tanzi; A I Bush
Journal:  Biochemistry       Date:  1999-06-15       Impact factor: 3.162

9.  Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Authors:  P Seubert; C Vigo-Pelfrey; F Esch; M Lee; H Dovey; D Davis; S Sinha; M Schlossmacher; J Whaley; C Swindlehurst
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

10.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Authors:  K Hensley; J M Carney; M P Mattson; M Aksenova; M Harris; J F Wu; R A Floyd; D A Butterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205
View more
  12 in total

1.  Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.

Authors:  Lila K Habib; Michelle T C Lee; Jerry Yang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Regulation of catalase enzyme activity by cell signaling molecules.

Authors:  Sumio Yano; Noriko Yano
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

3.  Autophagy Activation Alleviates Amyloid-β-Induced Oxidative Stress, Apoptosis and Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Abhishek Kumar Singh; Akalabya Bissoyi; Mahendra Pratap Kashyap; Pradeep Kumar Patra; Syed Ibrahim Rizvi
Journal:  Neurotox Res       Date:  2017-05-08       Impact factor: 3.911

4.  Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.

Authors:  Nathaniel G N Milton; Amrutha Chilumuri; Eridan Rocha-Ferreira; Amanda N Nercessian; Maria Ashioti
Journal:  ACS Chem Neurosci       Date:  2012-05-30       Impact factor: 4.418

5.  Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro.

Authors:  Amrutha Chilumuri; Mark Odell; Nathaniel G N Milton
Journal:  ACS Chem Neurosci       Date:  2013-09-09       Impact factor: 4.418

6.  Non-chaperone proteins can inhibit aggregation and cytotoxicity of Alzheimer amyloid β peptide.

Authors:  Jinghui Luo; Sebastian K T S Wärmländer; Astrid Gräslund; Jan Pieter Abrahams
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

7.  Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient.

Authors:  Amrutha Chilumuri; Maria Ashioti; Amanda N Nercessian; Nathaniel G N Milton
Journal:  J Neurodegener Dis       Date:  2013-05-16

8.  How ionic strength affects the conformational behavior of human and rat beta amyloids--a computational study.

Authors:  Zdeněk Kříž; Jiří Klusák; Zdena Krištofíková; Jaroslav Koča
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

Review 9.  Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment.

Authors:  Nathaniel G N Milton
Journal:  Drugs Aging       Date:  2004       Impact factor: 4.271

10.  Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease.

Authors:  Daniel Lancour; Josée Dupuis; Richard Mayeux; Jonathan L Haines; Margaret A Pericak-Vance; Gerard C Schellenberg; Mark Crovella; Lindsay A Farrer; Simon Kasif
Journal:  Alzheimers Res Ther       Date:  2020-09-02       Impact factor: 6.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.